Ticker >

Hind Bio Science share price

Hindustan Bio Sciences Ltd.

BSE: 532041 SECTOR: Pharmaceuticals & Drugs  9682   11   1

7.25
-0.14 (-1.89%)
BSE: 28 Mar 04:01 PM

Price Summary

Today's High

₹ 7.39

Today's Low

₹ 7.25

52 Week High

₹ 15.18

52 Week Low

₹ 5.15

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

7.43 Cr.

Enterprise Value

9.88 Cr.

No. of Shares

1.03 Cr.

P/E

265.57

P/B

9.77

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  0.74

CASH

0.01 Cr.

DEBT

2.46 Cr.

Promoter Holding

12.19 %

EPS (TTM)

₹  0.03

Sales Growth

114.19%

ROE

-5.28 %

ROCE

-1.1%

Profit Growth

92.18 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year114.19%
3 Year-22%
5 Year-2.21%

Profit Growth

1 Year92.18%
3 Year-179.38%
5 Year14.66%

ROE%

1 Year-5.28%
3 Year-35.91%
5 Year-19.77%

ROCE %

1 Year-1.1%
3 Year-13.82%
5 Year-7.27%

Debt/Equity

3.2888

Price to Cash Flow

-149.33

Interest Cover Ratio

-8.26222786293078

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 12.19 0
Sep 2023 12.19 0
Jun 2023 12.19 0
Mar 2023 12.19 0
Dec 2022 12.19 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.12668337841528.

 Limitations

  • The company has shown a poor profit growth of -179.381042989569% for the Past 3 years.
  • The company has shown a poor revenue growth of -21.9964366274926% for the Past 3 years.
  • Company has a poor ROE of -35.9085162889877% over the past 3 years.
  • Company has a poor ROCE of -13.8185907935126% over the past 3 years
  • Company has high Debt to Equity ratio of 3.2888.
  • Company has low Interest coverage ratio of -8.26222786293078.
  • Company has negative cash flow from operations of -0.0497694.
  • The company has a low EBITDA margin of -40.1987277459884% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 250.3957.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0.32 0.33 0 0.32 0.32
Total Expenditure 0.27 0.31 0.12 0.26 0.27
Operating Profit 0.05 0.02 -0.12 0.06 0.06
Other Income 0 0 0 0.01 0.02
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.05 0.02 -0.12 0.07 0.07
Tax 0 0 0 0 0
Profit After Tax 0.05 0.01 -0.12 0.07 0.07
Adjusted EPS (Rs) 0.05 0.01 -0.12 0.06 0.07

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 3.56 1.94 1.03 0.43 0.92
Total Expenditure 3.43 1.81 1.97 0.94 0.95
Operating Profit 0.13 0.14 -0.94 -0.51 -0.03
Other Income 0 0 0 0 0
Interest 0.01 0.01 0.01 0 0
Depreciation 0.01 0.01 0.01 0 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.11 0.12 -0.96 -0.51 -0.04
Tax 0 0.04 -0.02 0 0
Net Profit 0.11 0.08 -0.94 -0.52 -0.04
Adjusted EPS (Rs.) 0.11 0.08 -0.92 -0.5 -0.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.25 10.25 10.25 10.25 2.05
Total Reserves -8.09 -8.01 -8.95 -9.46 -1.3
Borrowings 2.47 1.67 0.73 1.07 1.12
Other N/C liabilities -0.03 -0.01 -0.01 -0.01 0
Current liabilities 0.99 1.65 1.45 1.12 1.42
Total Liabilities 5.6 5.55 3.48 2.97 3.28
Assets
Net Block 0.06 0.05 0.04 0.04 0.03
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 3.54 3.19 2.39 2.39 2.39
Other N/C Assets 0 0 0 0 0
Current Assets 2 2.31 1.05 0.54 0.86
Total Assets 5.6 5.55 3.48 2.97 3.28
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.11 0.12 -0.96 -0.51 -0.04
Adjustment 0.01 0.01 0.04 0.23 0.01
Changes in Assets & Liabilities -1.45 0.71 1.65 -0.06 -0.02
Tax Paid 0 -0.02 0.02 0 0
Operating Cash Flow -1.32 0.82 0.75 -0.34 -0.05
Investing Cash Flow -0.01 0 0 0 0
Financing Cash Flow 1.5 -0.81 -0.93 0.34 0.05
Net Cash Flow 0.17 0.01 -0.18 -0.01 0

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 12.19 12.19 12.19 12.19 12.19
j uma 0.01 0.01 0.01 0.01 0.01
j varun varma 0.02 0.02 0.02 0.02 0.02
super solutions india pri... 2.78 2.78 2.78 2.78 2.78
venkata rama mohan raju j... 9.39 9.39 9.39 9.39 9.39
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 87.81 87.81 87.81 87.81 87.81
chintalapati deepika 1.37 1.37 1.37 1.37 1.37
danlaw systems india l... 1.30 1.30 - 1.30 1.30
satyasai kolli 2.59 2.59 2.59 2.59 2.59
vandana yogesh bhosale 1.60 1.65 1.65 1.65 1.65
manish ramanlal shah 1.06 1.10 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Hind Bio Science - Quaterly Results31 Jan 2024, 2:30PM Hind Bio Science - Quaterly Results31 Jan 2024, 2:30PM Hind Bio Science - Quaterly Results31 Oct 2023, 3:20PM Hind Bio Science - Quaterly Results31 Oct 2023, 3:20PM Hind Bio Science - Quaterly Results31 Jul 2023, 3:03PM Hind Bio Science - Quaterly Results31 Jul 2023, 3:03PM Hind Bio Science - Quaterly Results31 Jul 2023, 3:03PM Hindustan Bio Sciences informs about outcome of board meeting 10 Mar 2023, 3:07PM Hind Bio Science - Quaterly Results31 Jan 2023, 3:52PM Hind Bio Science - Quaterly Results31 Jan 2023, 3:52PM Hind Bio Science - Quaterly Results31 Jan 2023, 3:52PM Hindustan Bio Sciences informs about on related party transaction28 Dec 2022, 5:17PM Hind Bio Science - Quaterly Results31 Oct 2022, 3:49PM Hind Bio Science - Quaterly Results31 Oct 2022, 3:49PM Hind Bio Science - Quaterly Results31 Oct 2022, 3:49PM Hind Bio Science - Quaterly Results29 Jul 2022, 4:06PM Hind Bio Science - Quaterly Results29 Jul 2022, 4:06PM Hind Bio Science - Quaterly Results29 Jul 2022, 4:06PM Hindustan Biosciences informs about revised compliance certificate4 Jun 2022, 3:17PM Hindustan Bio Sciences informs about compliance certificate18 Apr 2022, 5:19PM Hind Bio Science - Quaterly Results4 Feb 2022, 3:12PM Hind Bio Science - Quaterly Results4 Feb 2022, 3:12PM Hind Bio Science - Quaterly Results4 Feb 2022, 3:12PM Hindustan Biosciences informs about board meeting24 Jan 2022, 4:56PM Hindustan Bio Sciences informs about certificate20 Jan 2022, 4:22PM Hindustan Bio sciences informs about certificate23 Oct 2021, 11:42AM Hindustan Bio Sciences informs about voting results23 Jul 2021, 1:01PM Hindustan Bio Sciences informs about newspaper publication7 May 2021, 2:28PM Hindustan Bio Sciences informs about certificate16 Oct 2020, 3:13PM Hindustan Bio Sciences informs about outcome of board meeting 3 Sep 2020, 2:47PM

Hind Bio Science Stock Price Analysis and Quick Research Report. Is Hind Bio Science an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Hind Bio Science and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Hind Bio Science cash from the operating activity was Rs -0.0497694 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Hind Bio Science has a Debt to Equity ratio of 3.2888 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Hind Bio Science , the EPS growth was 92.1766686472569 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Hind Bio Science has OPM of -3.05704979374851 % which is a bad sign for profitability.
     
  • ROE: Hind Bio Science have a poor ROE of -5.27539321978088 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Hind Bio Science is Rs 7.25. One can use valuation calculators of ticker to know if Hind Bio Science share price is undervalued or overvalued.
Last Updated on:
Brief about Hind Bio Science
X